Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts

BACKGROUND: The aim of the present study was to validate the prognostic impact of CDX2 in patients with stage II colon cancer. METHODS: Two unbiased population-based cohorts representing all patients operated for stage II colon cancer in Denmark in 2002 and 2003. The CDX2 expression was evaluated by...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Torben Frøstrup, Kjær-Frifeldt, Sanne, Eriksen, Ann Christina, Lindebjerg, Jan, Jensen, Lars Henrik, Sørensen, Flemming Brandt, Jakobsen, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265279/
https://www.ncbi.nlm.nih.gov/pubmed/30425348
http://dx.doi.org/10.1038/s41416-018-0285-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265279/
https://www.ncbi.nlm.nih.gov/pubmed/30425348
http://dx.doi.org/10.1038/s41416-018-0285-5

Ejemplares similares